Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclic AMP signaling in trypanosomatids.

C Naula1, T Seebeck

  • 1University of Bern, Institute of General Microbiology, Switzerland.

Parasitology Today (Personal Ed.)
|January 19, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply from C. Wedekind and T. Seebeck.

Trends in ecology & evolution·2011
Same author

cAMP signalling in the kinetoplastid protozoa.

Current molecular medicine·2004
Same author

The regulatory subunit of a cGMP-regulated protein kinase A of Trypanosoma brucei.

European journal of biochemistry·2001
Same author

Genetic variants of the TbAT1 adenosine transporter from African trypanosomes in relapse infections following melarsoprol therapy.

Molecular and biochemical parasitology·2001
Same author

cAMP-specific phosphodiesterase TbPDE1 is not essential in Trypanosoma brucei in culture or during midgut infection of tsetse flies.

Molecular and biochemical parasitology·2001
Same author

Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle.

Microbes and infection·2001

Signal transduction pathways are key drug targets. Trypanosomatid cyclic nucleotide signaling enzymes differ from mammalian ones, presenting unique therapeutic opportunities.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Parasitology

Background:

  • Signal transduction pathway interference is a successful drug development strategy, with many top-selling drugs targeting these pathways.
  • Half of the most successful drugs modulate cellular signal transduction.
  • Signal transduction pathways in trypanosomatids remain largely unexplored as drug targets.

Purpose of the Study:

  • To summarize current knowledge on cyclic adenosine monophosphate (cAMP) signal transduction in trypanosomatids.
  • To highlight the potential of trypanosomatid-specific signaling pathways as drug targets.

Main Methods:

  • Literature review and synthesis of existing research on cAMP signaling in trypanosomatids.

Main Results:

Related Experiment Videos

  • Adenylyl cyclases and other cyclic nucleotide signaling enzymes in trypanosomatids exhibit significant differences compared to their mammalian counterparts.
  • This divergence suggests unique mechanisms of action and potential for targeted drug development.

Conclusions:

  • Trypanosomatid cyclic nucleotide signaling pathways represent a promising, yet underexplored, area for novel therapeutic interventions.
  • Targeting these distinct pathways could lead to the development of new drugs against trypanosomal diseases.